X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7211) 7211
Book Review (1370) 1370
Publication (426) 426
Book Chapter (29) 29
Newspaper Article (22) 22
Conference Proceeding (11) 11
Magazine Article (4) 4
Dissertation (3) 3
Newsletter (3) 3
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6717) 6717
humans (4954) 4954
animals (3067) 3067
female (3004) 3004
male (2595) 2595
oncology (2114) 2114
mice (2027) 2027
immunology (1849) 1849
middle aged (1776) 1776
interleukin-2 - administration & dosage (1720) 1720
adult (1690) 1690
immunotherapy (1667) 1667
aged (1290) 1290
interleukin-2 (1278) 1278
cancer (1175) 1175
dose-response relationship, drug (1094) 1094
interleukin-2 - therapeutic use (1005) 1005
treatment outcome (827) 827
recombinant interleukin-2 (812) 812
medicine, research & experimental (786) 786
recombinant proteins - administration & dosage (709) 709
pharmacology & pharmacy (702) 702
mice, inbred balb c (699) 699
cytokines (698) 698
lymphocytes (679) 679
abridged index medicus (674) 674
therapy (671) 671
antineoplastic combined chemotherapy protocols - therapeutic use (647) 647
research (641) 641
interleukin-2 - pharmacology (640) 640
interleukin-2 - adverse effects (598) 598
care and treatment (597) 597
melanoma (581) 581
health aspects (566) 566
mice, inbred c57bl (563) 563
expression (556) 556
time factors (509) 509
t cells (507) 507
t-lymphocytes - immunology (506) 506
recombinant proteins (504) 504
combined modality therapy (497) 497
high-dose interleukin-2 (484) 484
cells, cultured (483) 483
hematology (483) 483
chemotherapy (472) 472
killer cells, natural - immunology (432) 432
recombinant proteins - therapeutic use (427) 427
t-cells (426) 426
vaccines (421) 421
antineoplastic agents - therapeutic use (420) 420
drug administration schedule (420) 420
in-vivo (420) 420
rats (419) 419
interferon-alpha - administration & dosage (409) 409
antineoplastic agents - administration & dosage (401) 401
melanoma - drug therapy (393) 393
dendritic cells (389) 389
kidney neoplasms - drug therapy (388) 388
carcinoma, renal cell - drug therapy (387) 387
drug therapy (377) 377
immunization (373) 373
vaccination (373) 373
interleukin-2 - immunology (371) 371
antigens (370) 370
dosage and administration (369) 369
metastatic melanoma (368) 368
biochemistry & molecular biology (365) 365
kidney neoplasms - therapy (364) 364
immunotherapy - methods (363) 363
carcinoma, renal cell - therapy (358) 358
neoplasms - therapy (357) 357
interferon (356) 356
lymphocyte activation (356) 356
adolescent (355) 355
biotechnology & applied microbiology (355) 355
injections, subcutaneous (350) 350
cells (349) 349
interferon-alpha (347) 347
activated killer-cells (340) 340
medicine & public health (340) 340
analysis (339) 339
recombinant proteins - pharmacology (332) 332
colony-stimulating factor (331) 331
il-2 (331) 331
melanoma - therapy (331) 331
tumors (325) 325
flow cytometry (322) 322
cell biology (315) 315
dose-response relationship, immunologic (310) 310
immune response (310) 310
transplantation (299) 299
dose recombinant interleukin-2 (296) 296
neoplasm metastasis (295) 295
proteins (295) 295
clinical trials as topic (291) 291
lymphocyte activation - drug effects (288) 288
survival (286) 286
antibodies, monoclonal - therapeutic use (285) 285
medicine (282) 282
disease models, animal (280) 280
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7156) 7156
Russian (35) 35
German (30) 30
French (14) 14
Italian (4) 4
Chinese (2) 2
Danish (2) 2
Polish (2) 2
Spanish (2) 2
Dutch (1) 1
Georgian (1) 1
Hungarian (1) 1
Japanese (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 5, pp. 808 - 814
Journal Article
CANCER, ISSN 0008-543X, 04/2014, Volume 120, Issue 7, pp. 1010 - 1017
BACKGROUNDRecombinant interleukin-2 (rIL-2) induces cellular cytotoxicity against leukemia blasts. Patients with acute myeloid leukemia (AML) in first complete... 
SURVIVAL | NATURAL-KILLER-CELLS | ACUTE MYELOGENOUS LEUKEMIA | ADULTS | adjuvant therapy | HIGH-DOSE CYTARABINE | CANCER | INTENSIFICATION THERAPY | TRANSPLANTATION | phase 3 | acute myeloid leukemia | ONCOLOGY | recombinant interleukin-2 | immunotherapy | IN-VIVO | GROUP-B
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2006, Volume 12, Issue 23, pp. 7046 - 7053
Journal Article
Journal Article
Journal Article
Science Translational Medicine, ISSN 1946-6234, 06/2012, Volume 4, Issue 137, pp. 137ra74 - 137ra74
Journal Article
Neuroscience and Behavioral Physiology, ISSN 0097-0549, 11/2015, Volume 45, Issue 9, pp. 1095 - 1100
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 02/2016, Volume 22, Issue 3, pp. 680 - 690
Purpose: Aldesleukin, recombinant human IL2, is an effective immunotherapy for metastatic melanoma and renal cancer, with durable responses in approximately... 
METASTATIC MELANOMA | CTLA-4 BLOCKADE | ONCOLOGY | ALPHA-RECEPTOR | IMMUNOTHERAPY | REGULATORY T-CELLS | RECOMBINANT INTERLEUKIN-2 | HIGH-DOSE INTERLEUKIN-2 | ANTITUMOR-ACTIVITY | PHASE-I | CANCER | Neoplasms - metabolism | T-Lymphocytes, Regulatory - metabolism | Recombinant Fusion Proteins - pharmacology | Humans | Molecular Conformation | Male | Polyethylene Glycols - chemistry | Receptors, Interleukin-2 - chemistry | T-Lymphocytes, Regulatory - immunology | Lymphocytes, Tumor-Infiltrating | Melanoma, Experimental | CD8-Positive T-Lymphocytes - metabolism | Female | Interleukin-2 - chemistry | Antineoplastic Agents - pharmacology | Interleukin-2 - analogs & derivatives | Disease Models, Animal | Polyethylene Glycols - pharmacology | Prodrugs | Models, Molecular | Receptors, Interleukin-2 - metabolism | Recombinant Fusion Proteins - chemistry | Recombinant Proteins - pharmacology | Antineoplastic Agents - chemistry | Neoplasms - drug therapy | Drug Synergism | T-Lymphocytes, Regulatory - drug effects | Animals | Tumor Burden - drug effects | Neoplasms - immunology | CD8-Positive T-Lymphocytes - drug effects | Cell Line, Tumor | Interleukin-2 - pharmacology | Protein Binding | Immunologic Memory | Mice | CD8-Positive T-Lymphocytes - immunology | CTLA-4 Antigen - antagonists & inhibitors | Neoplasms - pathology | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2011, Volume 29, Issue 4, pp. 441 - 448
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2003, Volume 21, Issue 16, pp. 3127 - 3132
Purpose : This three-arm randomized study compares response rates and overall survival of patients with metastatic renal cell cancer (RCC) receiving high-dose... 
TRIAL | INTERFERON | MELANOMA | SUBCUTANEOUS INTERLEUKIN-2 | ONCOLOGY | HOME-THERAPY | PHASE-II | RECOMBINANT INTERLEUKIN-2 | CELL CARCINOMA | Prognosis | Interleukin-2 - administration & dosage | Humans | Middle Aged | Survival Analysis | Female | Kidney Neoplasms - pathology | Male | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms - drug therapy | Index Medicus
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 04/2012, Volume 18, Issue 7, pp. 2039 - 2047
Journal Article